UCB Pharma news from FiercePharma
News
Quick Cimzia launch overjoys UCB
UCB Pharma was delirious with glee when it managed to launch its new TNF inhibitor Cimzia for Read more...
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

